Atlantic Edge Private Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
SLAM
Atlantic Edge Private Wealth Management's BMY Position: Q2 2026 in Review
Atlantic Edge Private Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $2.41K and leaving 1,650 shares worth $95.1K. The position accounts for 0.02% of the portfolio, ranked #197.
Atlantic Edge Private Wealth Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $134K in Q1 2025. 1,005 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Atlantic Edge Private Wealth Management held 1,650 shares of Bristol-Myers Squibb worth $95.1K as of Q2 2026.
- Atlantic Edge Private Wealth Management sold 42 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.41K.
- Bristol-Myers Squibb made up 0.02% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #197 holding.
- Atlantic Edge Private Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Atlantic Edge Private Wealth Management's Bristol-Myers Squibb position peaked at $134K in Q1 2025.
- 1,005 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.